CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
- 4 Shares withheld for taxes EVP - Business Operations gave up 490 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 368 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 402 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 54,918 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
- 4 Grant or award Director acquired 3,530,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 2,353,000 shares at $8.50 ($20,000,500)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 217 shares (to pay taxes)
- 4 Shares withheld for taxes EVP - Business Operations gave up 579 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 434 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 468 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 723 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 41,861 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 8 of 11 · 206 filings